© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Diabetes
AHA: Fauci Says Long-term Follow Up Needed to Understand COVID-19 Effects
November 18, 2020
Dr. Anthony Fauci addresses the American Heart Association Scientific Sessions.
After Setbacks, Good News for Sotagliflozin in Heart Failure, CKD
November 17, 2020
After an FDA denial and a lost sponsor, sotagliflozin shows it can cut cardiovascular events and possibly treat a form of heart failure that has no approved therapies.
AHA: Four in Five Heart Failure Patients Fit Criteria for Farxiga
November 13, 2020
The findings are the first in a series of six studies involving a registry supported by drug makers in the diabetes, cardiovascular, and heart failure space.
Flu Shots Are More Important Than Ever for People with Diabetes, ASCVD
October 14, 2020
Flu increases the risk of heart attack, especially among people with diabetes and atherosclerotic cardiovascular disease (ASCVD). COVID-19 and the possibility of co-infection makes getting vaccinated against the flu particularly important this year.
Anti-VEGF Therapy for Diabetic Retinopathy Gets to the Root Cause
September 14, 2020
Drugs block the formation of tiny blood vessels in the retina that are prone to breaking open, resulting in bleeds that can cause serious vision impairment and blindness, explains ADA chief scientific and medical officer, Robert Gabbay, in this conclusion of a four-part video series.
Tackling Diabetes While Curbing Costs
July 23, 2020
Three healthcare organizations provide models for managing the disease and keeping a close eye on the bottom line.
Is Combination Therapy on the Horizon in Diabetic Macular Edema?
July 12, 2020
Patients with diabetic macular edema whose vision remains impaired even with the best available treatments may soon have a combination therapy.
Vascepa's Benefits For People With Diabetes Seen Amid Settlement of Patent Dispute
June 16, 2020
Results from REDUCE-IT trial presented at the ADA meeting show that the fish-oil pill is associated with cardiovascular disease protection among patients with diabetes.